Pulmonary resection for metastatic nonosteogenic sarcoma

Publisher Website
Google Scholar
Abstract
Analysis was made of 112 patients who underwent resection of metastatic pulmonary nodules for nonosteogenic sarcoma at the Mayo Clinic from 1950–76. The 5‐year post‐thoracotomy survival was 29% with a median survival of 18 months. There has been no substantial change between 1950 and 1976 in post‐thoracotomy survival among all patients who received this operation here. Prognosis was especially grim (p < 0.01) for patients with pre‐thoracotomy disease‐free intervals of < 12 months, and for those experiencing extra thoracic recurrences vs. further pulmonary recurrent tumor (p = .01) following thoracotomy. The following discriminants were not significantly associated with postthoracotomy survival: age, sex, histology, number of lesions fully excised, or site of lung lesions. We conclude that the therapeutic value of thoracotomy in the treatment of metastatic nonosteogenic sarcomas has not changed here during the past quarter of a century. Whether the recent more common use of thoracotomy in metastatic disease of this type is therapeutically worthwhile cannot be clearly determined from the data available.